HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1066071Generated: November 1, 2026
4-Bromoisoquinoline → 1-Tert-butoxycarbon-yl-4-(isoquinolin-4-yl)-4-hydroxypiperidine
https://huagongshe.com/reaction/1066071
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 4-Bromoisoquinoline | HCID 73743 | — |
| Reactant | tert-Butyl 4-oxopiperidine-1-carboxylate | HCID 735900 | — |
| Reactant | CID 53628100 | HCID 178418400 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | 1-Tert-butoxycarbon-yl-4-(isoquinolin-4-yl)-4-hydroxypiperidine | HCID 17789501 | 39% |
Reaction Steps
A solution of 6.46 gm (31.1 mMol) 4-bromoisoquinoline in 80 mL tetrahydrofuran was cooled to −100° C. under a nitrogen atmosphere. To this solution was added dropwise 28.7 mL (37.3 mmol) sec-butyllithium (1.3 M in hexanes) and the reaction mixture was allowed to stir for 1.5 hours. To the reaction mixture was then added dropwise a solution of 1-tert-butoxycarbonyl-4-piperidone in 20 mL tetrahydrofuran dropwise. The reaction mixture was then stirred for 18 hours at room temperature. The reaction mixture was then partitioned between ethyl acetate and 2N sodium hydroxide. The phases were separated and the aqueous phase extracted well with ethyl acetate. The organic phases were combined, washed saturated aqueous sodium chloride, dried over sodium sulfate and concentrated under reduced pressure. The residue was subjected to silica gel chromatography, eluting with 9:1 dichloromethane:methanol. Fractions containing product were combined and concentrated under reduced pressure to provide 3.95 gm (39%) 1-tert-butoxycarbonyl-4-(isoquin-olin-4-yl)-4-hydroxypiperidine as a yellow solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06242450B1 |
|---|
| Source dataset | uspto-grants-2001_06 |
|---|
| ORD ID | ord-b388d7a64f2440c28d10a991bda66947 |
|---|
| Source note | uspto-grants-2001_06 |
|---|